| Abigail F Kerns, | |
|
1215 Lee St, Charlottesville, VA 22908-7911 | |
| (434) 924-2231 | |
| (434) 924-9295 |
| Full Name | Abigail F Kerns |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 6 Years |
| Location | 1215 Lee St, Charlottesville, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548758311 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 31152 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Martha Jefferson Hospital | Charlottesville, VA | Hospital |
| University Of Virginia Medical Center | Charlottesville, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Virginia Physicians Group | 4880590728 | 1397 |
News Archive
In 1961, people in the suburb of Niles, Illinois, experienced what they termed a "cancer epidemic." Over a dozen children in the town were diagnosed with leukemia within a short time.
Small business owners are increasingly concerned about the law's impact, according to the U.S. Chamber of Commerce, while Karen Ignagni of the nation's biggest trade group of insurers says the nation's focus must move to reducing the cost of health care.
United Therapeutics Corporation and Lee's Pharmaceutical Holdings Ltd. announced today that they have entered into an exclusive agreement for the distribution of Remodulin (treprostinil) Injection in China. Remodulin is a subcutaneously or intravenously administered prostacyclin analogue for the treatment of pulmonary arterial hypertension. Lee's Pharmaceutical is a leading Chinese pharmaceutical company with both a strong cardiovascular focus and extensive commercialization experience.
Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients. Unfortunately, some of the most effective therapies also have toxic side effects that can pose serious health risks and reduce quality of life. In the October issue of Mayo Clinic Proceedings, two articles authored by Mayo researchers address the issue of how to balance the risks and benefits associated with MM treatments.
Economic pressures are forcing companies to employ their supply chains, primarily the sourcing and procurement functions, to contain costs and boost revenue, according to the 2009 Global Survey of Supply Chain Progress from CSC (NYSE: CSC), Supply Chain Management Review, the Council of Supply Chain Management Professionals (CSCMP) and Michigan State University (MSU).
› Verified 1 days ago
| Entity Name | University Of Virginia Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
In 1961, people in the suburb of Niles, Illinois, experienced what they termed a "cancer epidemic." Over a dozen children in the town were diagnosed with leukemia within a short time.
Small business owners are increasingly concerned about the law's impact, according to the U.S. Chamber of Commerce, while Karen Ignagni of the nation's biggest trade group of insurers says the nation's focus must move to reducing the cost of health care.
United Therapeutics Corporation and Lee's Pharmaceutical Holdings Ltd. announced today that they have entered into an exclusive agreement for the distribution of Remodulin (treprostinil) Injection in China. Remodulin is a subcutaneously or intravenously administered prostacyclin analogue for the treatment of pulmonary arterial hypertension. Lee's Pharmaceutical is a leading Chinese pharmaceutical company with both a strong cardiovascular focus and extensive commercialization experience.
Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients. Unfortunately, some of the most effective therapies also have toxic side effects that can pose serious health risks and reduce quality of life. In the October issue of Mayo Clinic Proceedings, two articles authored by Mayo researchers address the issue of how to balance the risks and benefits associated with MM treatments.
Economic pressures are forcing companies to employ their supply chains, primarily the sourcing and procurement functions, to contain costs and boost revenue, according to the 2009 Global Survey of Supply Chain Progress from CSC (NYSE: CSC), Supply Chain Management Review, the Council of Supply Chain Management Professionals (CSCMP) and Michigan State University (MSU).
› Verified 1 days ago
| Entity Name | Mep Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164483558 PECOS PAC ID: 5193610319 Enrollment ID: O20171212002233 |
News Archive
In 1961, people in the suburb of Niles, Illinois, experienced what they termed a "cancer epidemic." Over a dozen children in the town were diagnosed with leukemia within a short time.
Small business owners are increasingly concerned about the law's impact, according to the U.S. Chamber of Commerce, while Karen Ignagni of the nation's biggest trade group of insurers says the nation's focus must move to reducing the cost of health care.
United Therapeutics Corporation and Lee's Pharmaceutical Holdings Ltd. announced today that they have entered into an exclusive agreement for the distribution of Remodulin (treprostinil) Injection in China. Remodulin is a subcutaneously or intravenously administered prostacyclin analogue for the treatment of pulmonary arterial hypertension. Lee's Pharmaceutical is a leading Chinese pharmaceutical company with both a strong cardiovascular focus and extensive commercialization experience.
Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients. Unfortunately, some of the most effective therapies also have toxic side effects that can pose serious health risks and reduce quality of life. In the October issue of Mayo Clinic Proceedings, two articles authored by Mayo researchers address the issue of how to balance the risks and benefits associated with MM treatments.
Economic pressures are forcing companies to employ their supply chains, primarily the sourcing and procurement functions, to contain costs and boost revenue, according to the 2009 Global Survey of Supply Chain Progress from CSC (NYSE: CSC), Supply Chain Management Review, the Council of Supply Chain Management Professionals (CSCMP) and Michigan State University (MSU).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Abigail F Kerns, Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | Abigail F Kerns, 1215 Lee St, Charlottesville, VA 22908-7911 Ph: (434) 924-2231 |
News Archive
In 1961, people in the suburb of Niles, Illinois, experienced what they termed a "cancer epidemic." Over a dozen children in the town were diagnosed with leukemia within a short time.
Small business owners are increasingly concerned about the law's impact, according to the U.S. Chamber of Commerce, while Karen Ignagni of the nation's biggest trade group of insurers says the nation's focus must move to reducing the cost of health care.
United Therapeutics Corporation and Lee's Pharmaceutical Holdings Ltd. announced today that they have entered into an exclusive agreement for the distribution of Remodulin (treprostinil) Injection in China. Remodulin is a subcutaneously or intravenously administered prostacyclin analogue for the treatment of pulmonary arterial hypertension. Lee's Pharmaceutical is a leading Chinese pharmaceutical company with both a strong cardiovascular focus and extensive commercialization experience.
Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients. Unfortunately, some of the most effective therapies also have toxic side effects that can pose serious health risks and reduce quality of life. In the October issue of Mayo Clinic Proceedings, two articles authored by Mayo researchers address the issue of how to balance the risks and benefits associated with MM treatments.
Economic pressures are forcing companies to employ their supply chains, primarily the sourcing and procurement functions, to contain costs and boost revenue, according to the 2009 Global Survey of Supply Chain Progress from CSC (NYSE: CSC), Supply Chain Management Review, the Council of Supply Chain Management Professionals (CSCMP) and Michigan State University (MSU).
› Verified 1 days ago
Margaret K. Sande, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2231 Fax: 434-924-9295 | |
Aaron Frey, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2231 Fax: 434-924-9295 | |
Dr. Ursula Gailliot Koeze, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 459 Locust Ave, Mb 26, Charlottesville, VA 22902 Phone: 434-982-7150 Fax: 434-982-7147 | |
David R. Burt, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2231 Fax: 434-924-9295 | |
Mairin Smith, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 500 Martha Jefferson Dr, Charlottesville, VA 22911 Phone: 434-654-7154 | |
Avery Michienzi, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2231 Fax: 434-924-9295 | |
John S. Huff, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2231 Fax: 434-924-9295 |